Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: a randomised controlled 6-week trial.
暂无分享,去创建一个
H. Magnussen | H. Watz | A. Kirsten | J. Mo | H. Wray | R. Kay | Millie M Wang | Viktoria Samuelsson | Millie Wang